Jul 2026· Research, Society and Development· Vol 15, pp. e8215751452· 0 citations· 21 references
TL;DR
The synthesis identified six interdependent domains through which Field Medical can create scientific and system-level value: Scientific Mastery, Insight Intelligence, Center Development, System Navigation, Strategic Partnership, and Impact Measurement.
Abstract
Rare diseases create distinctive challenges for scientific communication and health-system organization because of small patient populations, heterogeneous phenotypes, limited natural history data, fragmented referral pathways, and persistent diagnostic delays. This narrative review aimed to synthesize the literature on Medical Science Liaison (MSL) practice and rare-disease ecosystems and to propose a pragmatic framework for Field Medical excellence. A targeted search of PubMed and publicly available professional guidance repositories was conducted through July 2026 using terms related to Medical Affairs, MSL competencies, rare diseases, diagnostic delay, real-world evidence, center development, scientific insights, and impact measurement. Sources were selected for conceptual relevance rather than exhaustive coverage. The synthesis identified six interdependent domains through which Field Medical can create scientific and system-level value: Scientific Mastery, Insight Intelligence, Center Development, System Navigation, Strategic Partnership, and Impact Measurement. The framework emphasizes scientific independence, contextual interpretation of uncertain evidence, longitudinal stakeholder engagement, translation of field insights into action, and evaluation through outcome-oriented indicators rather than activity counts alone. It is intended as an organizing model, not as a validated competency instrument. Future studies should test its content validity, feasibility, and association with measurable improvements in diagnostic readiness, research feasibility, stakeholder capability, and patient-centered care pathways.
Rare diseases affect millions globally but remain poorly understood due to low prevalence and fragmented healthcare responses. Patients face long diagnostic delays, known as the “diagnostic odyssey”, due to limited knowledge and awareness among healthcare professionals. This scoping review examines healthcare pro...
Stacey McGeown, Paul F. Slater, Felicity Hasson· Orphanet Journal of Rare Dis...· 1 citation
A conceptual Clinical Co-pilot Framework is proposed to position GenAI as a collaborative partner that supports clinicians rather than replaces them, which provides a conceptual basis for future empirical validation and may help inform the responsible implementation of GenAI in healthcare.
Lina Cheng, Chia-Yu Hung, Te-Nien Chien· International Journal of Adv...· 0 citations
This perspective paper outlines the conceptual foundations of the INFORM-RD research project (a patient-informed clinical platform to inform patient-centred decision-making for rare diseases), embedded at KU Leuven, Leuven Institute for Rare Diseases and University Hospitals Leuven, Belgium.
K. Demesure, Lien Beckers, Wendy Vansteenkiste et al.· Therapeutic Advances in Rare...· 0 citations
Summary There are over 10,000 rare diseases collectively affecting an estimated 250–450 million people globally. While these diseases are rare individually, their cumulative impact on patients, families, healthcare systems, and society is substantial. The incorporation of clinical outcome assessments (COAs) in clinical...
O. Aiyegbusi, N. Mccorry, M. Calvert et al.· EClinicalMedicine· 0 citations
Background/Objectives: Healthcare digital twins are being developed at scales ranging from individual organs to regional health systems. However, the literature at these different scales has largely evolved independently. This narrative review examines how the concept changes as the represented object grows, and propos...
L. Azamfirei, D. Bica, Andrei Calin Dragomir et al.· Healthcare· 0 citations
Key challenges identified included the lack of national disease registries, limited public awareness, underrepresentation of patient voices in decision-making, fragmented multidisciplinary care, and restricted access to diagnostics and advanced therapies.
A. Farrugia, A. Bahey, A. Tarawah et al.· Orphanet Journal of Rare Dis...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.